This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.
This activity has been designed to meet the educational needs of the interprofessional team, which includes neurologists and cardiologists, as well as other healthcare providers involved in the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA.
After participating in this educational activity, participants should be better able to:
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Valeria Caso, MD, PhD, faculty for this educational event, received research funding from Bayer; and consulting fees from Boehringer Ingelheim, Pfizer/BMS, Bayer, Mindmaze, Daiichi Sankyo, and Ever-NeuroPharma.
Manesh R. Patel, MD, faculty for this educational event, received research grants from AstraZeneca, Bayer, Janssen, Mytonomy, and Procyrion; and received consulting fees from Bayer, Janssen, and Novartis.
Mike Sharma, MD, MSc, FRCPC, faculty for this educational event, received research funding from Bayer, BMS, Janssen, AstraZeneca, Daiichi Sankyo, and consulting fees from Bayer and Novartis.
Ashkan Shoamanesh, MD, faculty for this educational event, received research funding from Bayer, and consulting fees from Bayer.
The following planners/reviewers/managers have disclosed:
Vin Kalathiveetil, PharmD, planner for this educational event, has no relevant financial relationships with ineligible companies.
William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.
Total CME, LLC., planners, and managers have no relevant commercial relationships to disclose.
All the relevant financial relationships for these individuals have been mitigated.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use their clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Jointly provided by Global Learning Collaborative (GLC), Duke Heart, and Total CME, LLC.
This activity is supported by an independent educational grant from Bayer HealthCare Pharmaceuticals.
During the period 2/27/2024 through 2/27/2025, registered participants wishing to receive continuing education credit for this activity must follow these steps:
1. Read the learning objectives and faculty disclosures.
2. Answer a pre-program question.
3. View the program.
4. Complete the post-test with a score of 100%.
5. Complete activity evaluation.
6. Apply for credit and either bank your credits or print your certificate.
For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.
Release Date:
Expiration Date:
